Company
Headquarters: Tokyo, Japan
Employees: 547
CEO: Mr. Hideumi Akizawa
¥37.20 Billion
JPY as of Jan. 1, 2026
US$237.4 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $102.42 B |
| Cencora, Inc. | $65.71 B |
| Cardinal Health, Inc. | $48.88 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.44 B |
| Henry Schein, Inc. | $9.32 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and neurovascular occlusion coils; and insulin pumps, X-ray angio systems, and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
WIN-Partners Co. Ltd has the following listings and related stock indices.
Stock: JPX: 3183